000 | 05182nam a2200781 i 4500 | ||
---|---|---|---|
001 | 20133149032 | ||
003 | CtWfDGI | ||
005 | 20201203121136.0 | ||
006 | m o d | ||
007 | cr zn||||uuuuu | ||
008 | 130726s2013 enkad ob 001 0 eng d | ||
020 | _z9781845938079 (alk. paper) | ||
040 |
_aCtWfDGI _beng _erda _cCtWfDGI |
||
050 | 1 | 4 |
_aRC311.2 _bT384 2013eb |
082 | 0 | 4 |
_a616.99/5075 _223 |
245 | 0 | 0 |
_aTuberculosis : _blaboratory diagnosis and treatment strategies / _cedited by Timothy D. McHugh, University College London, UK. |
264 | 1 |
_aWallingford, Oxfordshire, UK : _bCABI, _c2013. |
|
264 | 4 | _c©2013 | |
300 |
_a1 online resource (xii, 270 pages) : _billustrations, charts. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
490 | 1 |
_aAdvances in molecular and cellular microbiology ; _v21 |
|
520 | 3 | _aThis book includes 19 chapters and shows how the challenge of tuberculosis is currently being met, providing insights into the evidence base underlying developments in laboratory diagnosis and techniques, drug development and treatment, as well as measurement of drug resistance and development of vaccines. | |
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aIntroduction / Timothy McHugh -- Improving upon sputum smear microscopy for diagnosis of tuberculosis in resource-poor settings / Andrew Ramsay, Karen R Steingart, and Madhukar Pai -- Molecular diagnosis of active pulmonary tuberculosis / Anna Bateson, Kate Reddington, and Justin O'Grady -- Improving on the LJ slope : automated liquid culture / Miguel Viveiros, Diana Machado, Isabel Couto and Leonard Amaral -- Interferon gamma release assays in the diagnosis of latent tuberculosis infection / Ajit Lalvani, Manish Pareek -- Measuring TB immune responses in the lung : the correct target? / Ronan Breen, Marc Lipman -- Sniffing out TB / Ruth McNerney, Claire Turner -- Role of phenotypic methods for drug susceptibility testing of M. tuberculosis isolates in the era of MDR and XDR epidemics / Leonid Heifets -- Genotypic measures of antibiotic susceptibility / Vanessa Mathys, Barun Mathema, and Pablo Bifani -- Molecular tools for fast identification of resistance and characterization of MDR/XDR-TB / Dick van Soolingen -- Monitoring therapy by bacterial load / Denise M. O'Sullivan -- Modelling responses to tuberculosis treatment / G. R. Davies -- Measuring gene expression by quantitative PCR (qPCR) / Isobella Honeyborne -- Transcriptomic approaches to mapping responses to drug therapy for tuberculosis / Simon J. Waddell, Philip D. Butcher -- Mycobacterial lipid bodies and resuscitation-promoting factor dependency as potential biomarkers of response to chemotherapy / N. J. Garton, G. V. Mukamoloval, and M. R. Barer -- Clinical trials in tuberculosis chemotherapy : the challenges / Stephen H. Gillespie -- The identification of 2-aminothiazole-4-carboxylates (ATCs) as a new class of TB agent : a lesson in HIT identification / Geoff Coxon -- Rifamycins revisited / Martin J. Boeree -- Therapy of the XDR-TB patients with thioridazine :an old drug with new applications / Leonard Amaral, Marta Martins , Isabel Couto and Miguel Viveiros -- Vaccines for tuberculosis / Helen McShane. | |
506 | _aAccess limited to subscribing institution. | ||
530 | _aAlso available in print format. | ||
588 | _aTitle from PDF title page (viewed July 26, 2013). | ||
650 | 0 |
_aTuberculosis _xDiagnosis. |
|
650 | 0 |
_aTuberculosis _xTreatment. |
|
650 | 1 | 2 |
_aTuberculosis _xdiagnosis. |
650 | 2 | 2 | _aAntitubercular Agents. |
650 | 2 | 2 | _aDrug Discovery. |
650 | 2 | 2 | _aMolecular Diagnostic Techniques. |
650 | 4 | _aPesticides and Drugs; Control, (New March 2000) | |
650 | 4 | _aPesticide and Drug Resistance. | |
650 | 4 | _aHost Resistance and Immunity. | |
650 | 4 | _aPrion, Viral, Bacterial and Fungal Pathogens of Humans, (New March 2000) | |
650 | 4 | _aDiagnosis of Human Disease, (New March 2000) | |
650 | 4 | _aTechniques and Methodology. | |
650 | 7 |
_aMan. _2cabt |
|
650 | 7 |
_aMycobacterium tuberculosis. _2cabt |
|
650 | 7 |
_aAntituberculous agents. _2cabt |
|
650 | 7 |
_aDiagnostic techniques. _2cabt |
|
650 | 7 |
_aDrug development. _2cabt |
|
650 | 7 |
_aDrug resistance. _2cabt |
|
650 | 7 |
_aDrug therapy. _2cabt |
|
650 | 7 |
_aHuman diseases. _2cabt |
|
650 | 7 |
_aImmunization. _2cabt |
|
650 | 7 |
_aLaboratory diagnosis. _2cabt |
|
650 | 7 |
_aTuberculosis. _2cabt |
|
650 | 7 |
_aVaccination. _2cabt |
|
650 | 7 |
_aVaccine development. _2cabt |
|
650 | 7 |
_aVaccines. _2cabt |
|
655 | 0 | _aElectronic books. | |
690 | _aHH405 | ||
690 | _aHH410 | ||
690 | _aHH600 | ||
690 | _aVV210 | ||
690 | _aVV720 | ||
690 | _aZZ900 | ||
700 | 1 |
_aMcHugh, Timothy D. _q(Timothy Daniel), _eeditor of compilation. |
|
710 | 2 |
_aC.A.B. International, _eissuing body. |
|
776 | 0 | 8 |
_iPrint version: _tTuberculosis. _dOxfordshire : CAB International, c2013. _z9781845938079 _w(DLC)2012030958 |
830 | 0 |
_aAdvances in molecular and cellular microbiology ; _v21. |
|
856 | 4 | 0 |
_uhttps://dx.doi.org/10.1079/9781845938079.0000 _zClick here to access resource |
942 | _cEB | ||
999 |
_c313373 _d313373 |